Singapore’s ETF market just crossed $20.5 billion, with CPF and SRS holdings up 380%. Yet most investors here are still being sold expensive unit trusts, not cheap ETFs. I break down why banks have zero incentive to change a model earning them 1.5-5% upfront sales charges plus ongoing trailer fees, and why that fee drag compounds into a meaningful chunk of your retirement outcome over 20-30 years. But cheap doesn’t always mean safer—South Korea’s retail investors learned this painfully with leveraged ETFs tied to chip stocks. The real question isn’t ETF versus unit trust. It’s whether your adviser is being paid to help you, or paid regardless.
Key takeaways:
ETFs can cost 0.03%, unit trusts carry 5% sales charges plus 20-60% trailer fees
CPF and SRS ETF holdings grew 380%, yet fee compression isn’t happening in Singapore
Banks earn upfront sales charges and recurring trailer fees, creating misaligned incentives
South Korea’s leveraged ETF losses show cheap expense ratios don’t equal low risk
The right question to ask your adviser: are you being paid to help me, or paid regardless?
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
